Aggregation-induced emission luminogens reveal cell cycle-dependent telomerase activity in cancer cells. Issue 6 (2nd January 2021)

• Record Type: Journal Article
• Authors: Wu, Xia; Wu, Jun; Dai, Jun; Chen, Biao; Chen, Zhe; Wang, Shixuan; Wu, Feng; Lou, Xiaoding; Xia, Fan
• Is Part Of: National science review. Volume 8:Issue 6(2021)
• Publication Date: 2021-01-02
• Subjects: cell cycle -- TERT mRNA -- telomerase activity -- AIEgens -- biomarkers; Science -- Periodicals; 505
• DOI: 10.1093/nsr/nwaa306
• Languages: English
• ISSNs: 2095-5138

Abstract

Abstract: Telomerase acts as an important biomarker for tumor identification, and synthesizes telomeric repeats at the end of chromosome telomeres during the replicative phase of the cell cycle; thus, the expression level of telomerase changes as the cell cycle progresses. TERT mRNA expression and telomerase activity were significantly increased in over 80% of human cancers from tissue specimens. Although many efforts have been made in detecting the activity of TERT mRNA and active telomerase, the heterogeneous behavior of the cell cycle was overlooked, which might affect the accuracy of the detection results. Herein, the AIEgen-based biosensing systems of PyTPA-DNA and Silole-R were developed to detect the cellular level of TERT mRNA and telomerase in different cell cycles. As a result, the fluorescence signal of cancer cells gradually increased from G0/G1, G1/S to S phase. In contrast, both cancer cells arrested at G2/M phase and normal cells exhibited negligible fluorescence intensities. Compared to normal tissues, malignant tumor samples demonstrated a significant turn-on fluorescence signal. Furthermore, the transcriptomics profiling revealed that tumor biomarkers changed as the cell cycle progressed and biomarkers of CA9, TK1 and EGFR were more abundantly expressed at early S stage. In this vein, our study presented advanced biosensing tools for more accurate analysis of the cell-cycle-dependent activity of TERT mRNA and active telomerase in clinical tissue samples. Abstract : AIEgen-based biosensing system was developed to detect telomerase in different cell cycles and the fluorescence signal of cancer cells increased from G0/G1 to S phase. While, cancer cells arrested at G2/M phase and normal cells exhibited the negligible signal.